Literature DB >> 21330669

NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice.

Wanhua Yang1, Haochuan Li, Elizabeth Mayhew, Jessamee Mellon, Peter W Chen, Jerry Y Niederkorn.   

Abstract

PURPOSE: To explore the role of natural killer T (NKT) cells in the development of liver metastases in mice harboring intraocular melanomas.
METHODS: Cells derived from the cutaneous B16 melanoma cell line (B16LS9) were transplanted either into the vitreous body or under the spleen capsules of wild-type C57BL/6 mice and NKT-cell-deficient Jα18(-/-) and CD1d(-/-) mice. The development of liver metastases was evaluated by histopathology. The effect of NK cells on liver metastases was determined by selective depletion with anti-asialo-GM1 antiserum in vivo and NK-cell-mediated cytolysis of B16LS9 melanoma cells in vitro. The role of IL-10 and transforming growth factor (TGF)-β in the inhibition of liver NK resistance to liver metastases was determined by in vivo and in vitro neutralization with monoclonal antibodies.
RESULTS: Liver NKT cells, especially type I NKT cells, enhanced liver metastases arising from intraocular melanomas. NKT-cell-deficient mice developed significantly fewer liver metastases that were NK-cell dependent. Tumor-induced liver NKT cells, especially type I NKT cells, inhibited liver NK-cell cytotoxicity by an IL-10-dependent process.
CONCLUSIONS: NKT cells exert protective effects in many murine tumor models. However, the present results reveal that NKT cells exacerbate liver metastases arising from intraocular melanomas. To the authors' knowledge, this is the first report that liver NKT cells, especially type I NKT cells, inhibit liver NK-cell antimetastatic activity by the production of IL-10. These results suggest that hepatic NKT cell activity can have an important effect in the immune surveillance of liver metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330669      PMCID: PMC3109018          DOI: 10.1167/iovs.10-7067

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

1.  Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.

Authors:  G Eberl; R Lees; S T Smiley; M Taniguchi; M J Grusby; H R MacDonald
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

2.  B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC).

Authors:  C E Diaz; D Rusciano; S Dithmar; H E Grossniklaus
Journal:  Curr Eye Res       Date:  1999-02       Impact factor: 2.424

3.  Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains.

Authors:  F Davodeau; M A Peyrat; A Necker; R Dominici; F Blanchard; C Leget; J Gaschet; P Costa; Y Jacques; A Godard; H Vie; A Poggi; F Romagné; M Bonneville
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

5.  Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model.

Authors:  S A Dithmar; D A Rusciano; C A Armstrong; M J Lynn; H E Grossniklaus
Journal:  Curr Eye Res       Date:  1999-11       Impact factor: 2.424

6.  Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity.

Authors:  D H Hsu; K W Moore; H Spits
Journal:  Int Immunol       Date:  1992-05       Impact factor: 4.823

7.  The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II.

Authors:  D M Albert
Journal:  Am J Ophthalmol       Date:  1997-06       Impact factor: 5.258

8.  Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells.

Authors:  S Norris; D G Doherty; C Collins; G McEntee; O Traynor; J E Hegarty; C O'Farrelly
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

9.  Protocols for the examination of tumors of diverse sites: introduction. Cancer Committee, College of American Pathologists.

Authors:  E H Hammond; C C Compton
Journal:  Arch Pathol Lab Med       Date:  1999-01       Impact factor: 5.534

10.  Induction of anterior chamber-associated immune deviation requires an intact, functional spleen.

Authors:  J W Streilein; J Y Niederkorn
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  27 in total

1.  Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.

Authors:  Sudha Neelam; Jessamee Mellon; Amber Wilkerson; Jerry Y Niederkorn
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

2.  Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.

Authors:  H J Blumenfeld; R Tohn; S M M Haeryfar; Y Liu; P B Savage; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

Review 3.  Biology of advanced uveal melanoma and next steps for clinical therapeutics.

Authors:  Jason J Luke; Pierre L Triozzi; Kyle C McKenna; Erwin G Van Meir; Jeffrey E Gershenwald; Boris C Bastian; J Silvio Gutkind; Anne M Bowcock; Howard Z Streicher; Poulam M Patel; Takami Sato; Jeffery A Sossman; Mario Sznol; Jack Welch; Magdalena Thurin; Sara Selig; Keith T Flaherty; Richard D Carvajal
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-01       Impact factor: 4.693

4.  NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.

Authors:  Leila Sadegh; Peter W Chen; Joseph R Brown; Zhiqiang Han; Jerry Y Niederkorn
Journal:  Int J Cancer       Date:  2015-02-27       Impact factor: 7.396

Review 5.  Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.

Authors:  Mark A Exley; Lydia Lynch; Bindu Varghese; Michael Nowak; Nadia Alatrakchi; Steven P Balk
Journal:  Clin Immunol       Date:  2011-05-13       Impact factor: 3.969

Review 6.  The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Cancer Immunol Immunother       Date:  2014-01-03       Impact factor: 6.968

Review 7.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

8.  TCRα-TCRβ pairing controls recognition of CD1d and directs the development of adipose NKT cells.

Authors:  Joshua A Vieth; Joy Das; Fanomezana M Ranaivoson; Davide Comoletti; Lisa K Denzin; Derek B Sant'Angelo
Journal:  Nat Immunol       Date:  2016-11-21       Impact factor: 25.606

9.  Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.

Authors:  Susan Achberger; Wayne Aldrich; Raymond Tubbs; John W Crabb; Arun D Singh; Pierre L Triozzi
Journal:  Mol Immunol       Date:  2013-12-25       Impact factor: 4.407

Review 10.  Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives.

Authors:  Xuezhen Zeng; Simon E Ward; Jingying Zhou; Alfred S L Cheng
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.